The need for biomarkers in amyotrophic lateral sclerosis drug development

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)11-12
Number of pages2
JournalNeurology
Volume72
Issue number1
DOIs
StatePublished - Jan 6 2009

Fingerprint

Drug Design
Amyotrophic Lateral Sclerosis
Biomarkers
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

The need for biomarkers in amyotrophic lateral sclerosis drug development. / Wagner, Kathryn Rae.

In: Neurology, Vol. 72, No. 1, 06.01.2009, p. 11-12.

Research output: Contribution to journalArticle

@article{c019cd283a0948228b6a5428f994ad9f,
title = "The need for biomarkers in amyotrophic lateral sclerosis drug development",
author = "Wagner, {Kathryn Rae}",
year = "2009",
month = "1",
day = "6",
doi = "10.1212/01.wnl.0000338538.18938.9d",
language = "English (US)",
volume = "72",
pages = "11--12",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - The need for biomarkers in amyotrophic lateral sclerosis drug development

AU - Wagner, Kathryn Rae

PY - 2009/1/6

Y1 - 2009/1/6

UR - http://www.scopus.com/inward/record.url?scp=63849306269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63849306269&partnerID=8YFLogxK

U2 - 10.1212/01.wnl.0000338538.18938.9d

DO - 10.1212/01.wnl.0000338538.18938.9d

M3 - Article

C2 - 19122026

AN - SCOPUS:63849306269

VL - 72

SP - 11

EP - 12

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 1

ER -